IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
IL-17 producing mast cells contribute to synovial inflammation in non-psoriatic and psoriatic spondyloarthritis ; volume:9 ; number:2 ; day:23 ; month:11 ; year:2011 ; pages:1 ; date:12.2011
Journal of translational medicine ; 9, Heft 2 (23.11.2011), 1, 12.2011
- Creator
-
Noordenbos, Troy
- Contributor
-
Yeremenko, Nataliya
Gofita, Ioana
Tak, Paul Peter
Cañete, Juan
Baeten, Dominique
SpringerLink (Online service)
- DOI
-
10.1186/1479-5876-9-S2-P47
- URN
-
urn:nbn:de:1111-2016041439871
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Noordenbos, Troy
- Yeremenko, Nataliya
- Gofita, Ioana
- Tak, Paul Peter
- Cañete, Juan
- Baeten, Dominique
- SpringerLink (Online service)
Other Objects (12)
Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?
Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
Cardiovascular Comorbidities in Psoriatic Disease
Treatment recommendations for psoriatic arthritis
Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?
Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
Cardiovascular Comorbidities in Psoriatic Disease
Treatment recommendations for psoriatic arthritis
Distinct synovial immunopathology in Behçet disease and psoriatic arthritis
Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis
Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Clinical Characteristics of Registry Participants with Psoriatic Arthritis Initiating Guselkumab: An Analysis from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?
Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features
Cardiovascular Comorbidities in Psoriatic Disease